OOIR: Observatory of International Research

Papers

(The H4-Index of Globalization and Health is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Comprehensive Medical Support in Complex Emergencies (CMSCE): pilot course review	112
North Korea’s COVID-19 policy dilemma: epidemic prevention conflicting with trade	89
Correction: Assessing the effects of mining projects on child health in sub-Saharan Africa: a multi-country analysis	76
National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics	72
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response	71
The alcohol industry’s involvement with road safety NGOs	68
Rain, rain, go away, come again another day: do climate variations enhance the spread of COVID-19?	65
Capturing sources of health system legitimacy in fragmented conflict zones under different governance models: a case study of northwest Syria	57
Cross-border utilization of cancer care by patients in the US and Mexico – a survey of Mexican oncologists	56
Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era	56
Constructing public–private partnerships to undermine the public interest: critical discourse analysis of Working Together published by the International Alliance for Responsible Drinking	54
Securing the rights and health of domestic workers: the importance of ratifying the ILO’s C189	42
Lobbying and nutrition policy in Canada: a quantitative descriptive study on stakeholder interactions with government officials in the context of Health Canada’s Healthy Eating Strategy	41
Reserve antibiotics: overcoming limitations of evidence generated from regulatory approval trials	40
Characteristics and outcomes of the drug patent linkage system in China	40
From proposal to compromise: the TRIPS waiver debate and the crisis of WTO decision-making	39
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region	39
Food industry degrowth as a public health strategy: the case of ultra processed baked goods	38
Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020	38
The politics of glyphosate regulation: lessons from Sri Lanka’s short-lived ban	38
From isolation to revival: trade recovery amid global health crises	37
Financing of health services for undocumented immigrants in Iran: common challenges and potential solutions	36
Food insecurity, COVID-19 and diets in Fiji – a cross-sectional survey of over 500 adults	34
Learning from COVID-19: government leaders’ perspectives to improve emergency risk communication	34
“We have to look deeper into why”: perspectives on problem identification and prioritization of women’s and girls’ health across United Nations agencies	34

Vaccine nationalism will persist: global public goods need effective engagement of global citizens	34
Future health expenditure in the BRICS countries: a forecasting analysis for 2035	34
Safeguarding health in bilateral investment treaties: the Uruguayan experience	32
“When there is no money, that is when I vomit blood”: the domino effect and the unfettered lethal exploitation of Black labor on Dominican sugar plantations	30
Geographical and practical challenges in the implementation of digital health passports for cross-border COVID-19 pandemic management: a narrative review and framework for solutions	30
GDP per capita and physician migration across world regions, 2000–2021	30